Brought to you by:
CMS considers new approaches to quality payment program with MVPs
The Centers for Medicare & Medicaid Services (CMS) are exploring strategies to enhance the Quality Payment Program (QPP), underscoring an effort to boost healthcare quality and efficiency. Launched on Jan. 1, 2017, the QPP was designed to inspire clinicians to…
SVS membership empowers surgeons in and out of the OR
The SVS emphasizes the role vascular surgeons play in advancing treatments for vascular diseases, offering a range of benefits through its membership to support these professionals inside and outside the operating room (OR). “SVS membership equips members with the tools…
End of an era: Schanzer and Robinson leave legacy of VAM innovation
As this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) approaches, it marks the end of an era for Andres Schanzer, MD, and William Robinson, MD, who have played integral roles in shaping the event’s trajectory. Schanzer’s leadership…
Vascular surgery Entrustable Professional Activities available to view
The American Board of Surgery (ABS) has unveiled the 15 proposed core Entrustable Professional Activities (EPAs) that will be evaluated in vascular surgery residents. They are: cerebrovascular disease; dialysis access; traumatic/iatrogenic vascular injury; peripheral artery aneurysms; claudication; chronic limb-threatening ischemia;…
The ability of ChatGPT to further patient education and aid surgeons
ChatGPT 4.0 was able to provide a mean accuracy rating of 4.4 on a Likert scale of 5 (1=very poor; 5=excellent) across 15 patient-level questions designed to assess the ability of the artificial intelligence (AI)-driven large language model to provide…
Statewide performance metric ‘profoundly’ increases rate of EVAR surveillance
A statewide collaborative between 35 hospital systems and a large insurance provider showed that the implementation of a performance metric linked with financial reimbursement designed to improve postoperative surveillance of patients who underwent endovascular aneurysm repair (EVAR) for abdominal aortic…
Abbott’s Esprit BTK scaffold system given US FDA approval for CLTI treatment
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is…
Interim analysis provides early window into real-world Alto stent graft outcomes
In a podium-first presentation on the final day of the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK), Sean Lyden (Cleveland Clinic, Cleveland, USA) disclosed an interim analysis from the JAGUAR trial and, in doing so, gave delegates…
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB) angioplasty with or without bare metal stent nor drug-eluting stent (DES), when used in the femoropopliteal…
Prosthetic valve implantation shows “vast” improvements in deep chronic venous insufficiency
“The surgical challenges of repairing deep venous reflux have been present for more than a generation. It is worth reflecting on the fact that this new technology has made the majority of patients vastly better,” were the words of principal…